PATZ1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.774300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.841500E-02
Normal-vs-Stage2
1.423040E-04
Normal-vs-Stage3
3.954100E-04
Normal-vs-Stage4
3.757800E-02
Stage1-vs-Stage2
1.695760E-02
Stage1-vs-Stage3
1.255020E-03
Stage1-vs-Stage4
2.514400E-01
Stage2-vs-Stage3
4.462200E-02
Stage2-vs-Stage4
5.618600E-01
Stage3-vs-Stage4
6.432200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.563600E-04
Normal-vs-AfricanAmerican
4.368000E-02
Normal-vs-Asian
2.308300E-02
Caucasian-vs-AfricanAmerican
2.883200E-01
Caucasian-vs-Asian
8.339200E-01
AfricanAmerican-vs-Asian
5.197800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.159400E-04
Normal-vs-Female
3.078200E-03
Male-vs-Female
5.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.159900E-02
Normal-vs-Age(41-60Yrs)
3.85259999999832E-05
Normal-vs-Age(61-80Yrs)
3.978600E-03
Normal-vs-Age(81-100Yrs)
2.641800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.195000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.825400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.048800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.587000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.019200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.199400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.778900E-03
Normal-vs-Daily Drinker
9.623900E-04
Normal-vs-Weekly Drinker
1.480090E-03
Normal-vs-Occasional Drinker
8.186000E-02
Normal-vs-Social Drinker
1.198500E-03
Non Drinker-vs-Daily Drinker
8.008400E-01
Non Drinker-vs-Weekly Drinker
7.157400E-01
Non Drinker-vs-Occasional Drinker
2.589400E-01
Non Drinker-vs-Social Drinker
6.257200E-01
Daily Drinker-vs-Weekly Drinker
8.782800E-01
Daily Drinker-vs-Occasional Drinker
2.277800E-01
Daily Drinker-vs-Social Drinker
4.497200E-01
Weekly Drinker-vs-Occasional Drinker
2.369400E-01
Weekly Drinker-vs-Social Drinker
3.942400E-01
Occasional Drinker-vs-Social Drinker
5.076000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.593900E-02
Normal-vs-Grade 2
2.554400E-02
Normal-vs-Grade 3
2.102300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.963900E-02
Grade 1-vs-Grade 3
1.371960E-01
Grade 1-vs-Grade 4
7.593900E-02
Grade 2-vs-Grade 3
5.246600E-01
Grade 2-vs-Grade 4
2.554400E-02
Grade 3-vs-Grade 4
2.102300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.175100E-04
Normal-vs-NonDiabetic
2.720400E-03
Diabetic-vs-NonDiabetic
1.272590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.724600E-03
Normal-vs-NoPancreatitis
2.064500E-03
Pancreatitis-vs-NoPancreatitis
5.145800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.037600E-02
Normal-vs-N1
1.243650E-04
N0-vs-N1
4.713800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.039200E-03
Normal-vs-TP53-NonMutant
4.034500E-02
TP53-Mutant-vs-TP53-NonMutant
8.446300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
